Morten Herholdt's Stock Ratings

HSBC Analyst

Morten Herholdt is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025

Overall Average Return

-5.72%

Smart Score

40%

Overall Average Return Percentile

27th

Number of Ratings

17
Buy NowGet Alert
10/30/2024LHBuy Now
Labcorp Holdings
$249.52
Morten Herholdt39%
UpgradeHold → BuyGet Alert
05/08/2024ZTSBuy Now
Zoetis
$163.0438%
Morten Herholdt39%
$230 → $225MaintainsBuyGet Alert
05/03/2024BIIBBuy Now
Biogen
$125.80171.86%
Morten Herholdt39%
$339 → $342MaintainsBuyGet Alert
04/24/2024GILDBuy Now
Gilead Sciences
$102.55-32.72%
Morten Herholdt39%
→ $69UpgradeReduce → HoldGet Alert
04/18/2024JNJBuy Now
Johnson & Johnson
$151.3512.32%
Morten Herholdt39%
$169 → $170UpgradeHold → BuyGet Alert
03/05/2024BLUEBuy Now
bluebird bio
$4.97-79.48%
Morten Herholdt39%
$2.31 → $1.02MaintainsReduceGet Alert
09/06/2023LHBuy Now
Laboratory Corp
$249.52-15.84%
Morten Herholdt39%
→ $210Initiates → HoldGet Alert
09/06/2023ZTSBuy Now
Zoetis
$163.0441.07%
Morten Herholdt39%
→ $230Initiates → BuyGet Alert
09/06/2023UNHBuy Now
UnitedHealth Group
$290.4285.94%
Morten Herholdt39%
→ $540Initiates → HoldGet Alert
09/06/2023LIVNBuy Now
LivaNova
$44.4017.12%
Morten Herholdt39%
→ $52Initiates → HoldGet Alert
09/06/2023JNJBuy Now
Johnson & Johnson
$151.3515.63%
Morten Herholdt39%
→ $175Initiates → HoldGet Alert
09/06/2023IQVBuy Now
IQVIA Hldgs
$142.8282.05%
Morten Herholdt39%
→ $260Initiates → BuyGet Alert
09/06/2023GILDBuy Now
Gilead Sciences
$102.55-30.77%
Morten Herholdt39%
→ $71Initiates → ReduceGet Alert
09/06/2023BLUEBuy Now
bluebird bio
$4.97-15.29%
Morten Herholdt39%
→ $4.21Initiates → BuyGet Alert
09/06/2023BIIBBuy Now
Biogen
$125.80186.17%
Morten Herholdt39%
→ $360Initiates → BuyGet Alert
09/06/2023AMGNBuy Now
Amgen
$270.0018.52%
Morten Herholdt39%
→ $320Initiates → BuyGet Alert
09/06/2023ATNMBuy Now
Actinium Pharma
$1.60624.46%
Morten Herholdt39%
→ $11.6Initiates → BuyGet Alert